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Background: Neural crest cells (NCCs) are a transient embryonic cell type that give rise to a wide spectrum of
derivatives, including neurons and glia of the sensory and autonomic nervous system, melanocytes and connective
tissues in the head. Lineage-tracing and functional studies have shown that trunk NCCs migrate along two distinct
paths that correlate with different developmental fates. Thus, NCCs migrating ventrally through the anterior somite
form sympathetic and sensory ganglia, whereas NCCs migrating dorsolaterally form melanocytes. Although the
mechanisms promoting migration along the dorsolateral path are well defined, the molecules providing positional
identity to sympathetic and sensory-fated NCCs that migrate along the same ventral path are ill defined. Neuropilins
(Nrp1 and Nrp2) are transmembrane glycoproteins that are essential for NCC migration. Nrp1 and Nrp2 knockout
mice have disparate phenotypes, suggesting that these receptors may play a role in sorting NCCs biased towards
sensory and sympathetic fates to appropriate locations.
Results: Here we have combined in situ hybridisation, immunohistochemistry and lineage-tracing analyses to
demonstrate that neuropilins are expressed in a non-overlapping pattern within NCCs. Whereas Nrp1 is expressed
in NCCs emigrating from hindbrain rhombomere 4 (r4) and within trunk NCCs giving rise to sympathetic and sensory
ganglia, Nrp2 is preferentially expressed in NCCs emigrating from r2 and in trunk NCCs giving rise to sensory ganglia.
By generating a tamoxifen-inducible lineage-tracing system, we further demonstrate that Nrp2-expressing NCCs
specifically populate sensory ganglia including the trigeminal ganglia (V) in the head and the dorsal root ganglia in
the trunk.
Conclusions: Taken together, our results demonstrate that Nrp1 and Nrp2 are expressed in different populations of
NCCs, and that Nrp2-expressing NCCs are strongly biased towards a sensory fate. In the trunk, Nrp2-expressing NCCs
specifically give rise to sensory ganglia, whereas Nrp1-expressing NCCs likely give rise to both sensory and sympathetic
ganglia. Our findings therefore suggest that neuropilins play an essential role in coordinating NCC migration with fate
specification.
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Neural crest cells (NCCs) are transient embryonic cells
that generate a wide spectrum of derivatives. Based on
their origin along the anteroposterior axis, NCCs are
broadly divided into different populations that give rise to
a restricted set of derivatives. Cranial NCCs arise anterior
to the fifth somite, and form derivates such as sensory,
sympathetic, and parasympathetic ganglia, connective tis-
sue, bone, cartilage, and muscle tendons of the head [1].* Correspondence: quenten.schwarz@health.sa.gov.au
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unless otherwise stated.Trunk NCCs arise posterior to the fourth somite, and give
rise to cell types such as sympathetic and sensory neurons,
adrenal chromaffin cells, and melanocytes [2]. Vagal NCCs
arise from the level of somites 1 to 7, and produce enteric
NCCs that form the neurons and glia of the enteric ner-
vous system [3], and other cell types such as cardiac NCCs
(level of somites 1 to 3) that form vascular smooth muscle
lining the great arteries and contribute to the aortic–
pulmonary septum [4].
Even within these anatomically defined domains, NCCs
can be further subdivided by additional properties, includ-
ing their migration path and their developmental fate
[5-7]. For example, cranial NCCs migrate in a segmentedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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This segmentation is critical for the correct formation and
positioning of cranial NCC derivatives, and is under the
control of cell intrinsic guidance receptors and signals
provided by the environment in which NCCs travel and
ultimately differentiate [8,9]. Trunk NCCs also migrate
along distinct paths that correlate with their developmen-
tal fate [5]. Thus, NCCs migrate ventrally, and either stop
within the sclerotome to give rise to sensory neurons and
glia within the dorsal root ganglia (DRG), or migrate to-
wards the dorsal aorta to give rise to the neurons and glia
of the sympathetic nervous system. A proportion of these
ventrally migrating NCCs that initially migrate along
axonal pathways also give rise to melanocytes [10]. By
contrast, NCCs migrating dorsolaterally between the der-
momyotome and epidermis give rise only to melanocytes.
A fundamental question for this field is how NCCs navi-
gate their environment to position themselves in appropri-
ate locations.
There is mounting evidence from chick and mouse
studies supporting the notion that NCCs migrating
dorsolaterally are specified at the time of delamination
[6,11-13], and that lineage-specific expression of cell sur-
face receptors promotes migration along this path [5].
Indeed, several receptor–ligand pairs, including the Slit/
ROBO [14], Eph/ephrin [11], endothelin/EDNR [11],
and Steel factor/KIT [15,16] families have been impli-
cated in permitting access to the dorsolateral path. By
contrast, there are two competing models to explain the
timing at which ventrally migrating NCCs become speci-
fied towards the sensory or sympathetic lineages. On the
one hand, it is proposed that this population of NCCs
are specified prior to or at the time of delamination, and
that lineage-specific properties promote migration along
restricted pathways. This notion is derived from the
findings that neurogenin 2 (Ngn2)-expressing NCCs are
strongly biased towards a sensory fate in mice [17], and
that nociceptive neurons arise specifically from contral-
aterally migrating NCCs within the chick neural tube
[18]. Specification of pre-migratory NCCs is also sup-
ported by lineage-tracing experiments detailing a spatio-
temporal fate map of sympathetic- and sensory-fated
cells within the chick dorsal neural tube [19]. However,
using in vivo optical imaging to analyse the behaviour of
single cells, McKinney and colleagues recently found
that pre-migratory NCCs in the chick lack positional
identity or fate prior to delamination [20], but rather,
they migrate from the neural tube stochastically and rap-
idly change their expression profiles as they migrate.
This and other lineage/transplantation studies in chick
support an alternative model in which migrating NCCs
are proposed to be multipotent, becoming specified by
their environment only as they migrate towards or at
their target regions [21-23].The molecular cues that cause some ventrally migrat-
ing NCCs to remain near the neural tube to form sen-
sory ganglia, while others continue migrating to adopt
other fates (e.g. sympathetic ganglia) remain ill defined.
In chick, the chemokine receptor CXCR4 is expressed in
a specific subset of early migrating NCCs to control
their migration towards a source of SDF1 around the an-
lagen of the sympathetic ganglia [24,25]. Neuropilins
(Nrp1 and Nrp2) are transmembrane receptors for guid-
ance molecules of the class 3 semaphorin (SEMA3) family
and for heparin-binding isoforms of vascular endothelial
growth factor (VEGF) [26]. Nrp1 and Nrp2 are expressed
in both cranial NCCs and ventrally migrating trunk NCCs,
and are required for proper segmentation of the peripheral
nervous system [27-30]. Notably, phenotypic analysis of
single Nrp1 or Nrp2 knockout embryos identified distinct
migration defects in different NCC lineages. In the head,
NCCs emigrating from r4 are misguided in Nrp1 knock-
out embryos [31], while NCCs emigrating from r2 are
misguided in Nrp2 knockout embryos [31,32]. Accord-
ingly, neurons arising from these populations of cranial
NCCs are ectopically positioned within neuropilin knock-
out embryos: neurons from the facio-acoustic ganglia
(VII-VIII) are ectopically positioned in Nrp1 knockout
embryos, while neurons from the trigeminal ganglia (V)
are ectopically positioned in Nrp2 knockout embryos
[31,32]. These lineage-specific NCC defects also extend to
the trunk, where Nrp1 knockout embryos have ectopically
placed neurons in the sympathetic and sensory nervous
systems, and Nrp2 knockout embryos have misplaced
neurons in the sensory nervous system [28,33,34]. In com-
bination with expression analyses, these observations sug-
gest that neuropilins may be required for the migration of
distinct populations of NCCs, and that this may be con-
trolled by the restricted expression of Nrp1 and Nrp2 in
NCCs biased towards sympathetic and/or sensory fates
[28]. However, to date, this notion has lacked definitive
support from co-expression analyses and fate mapping of
neuropilin-expressing NCCs.
Here we have combined in situ hybridisation, immu-
nohistochemistry and lineage-tracing analyses to directly
compare the expression of Nrp1 and Nrp2 in migrating
NCCs. Our results demonstrate that these receptors are
expressed in a non-overlapping pattern within different
populations of cranial and trunk NCCs. Whereas Nrp1
is expressed in cranial NCCs migrating out of hindbrain
r4 and within trunk NCCs migrating towards the sympa-
thetic and sensory ganglia, Nrp2 is preferentially expressed
in cranial NCCs migrating out of r2 and in trunk NCCs
migrating towards and positioned within the sensory gan-
glia. To determine whether Nrp2-expressing NCCs are
fate-restricted towards the sensory lineage, we generated a
tamoxifen-inducible Cre/LoxP tracing system to genetic-
ally label and lineage-trace this population of cells. In
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previous phenotypic analyses [33,34], our finding that
Nrp2-expressing NCCs give rise to sensory neurons in the
DRG and not the sympathetic chain identifies an essential
role for neuropilins in coordinating NCC migration with
fate specification.
Results and discussion
Nrp1 and Nrp2 are expressed in different populations of
cranial NCCs
Previous studies, including our own, demonstrated that
Nrp1 and Nrp2 knockout mice have non-overlapping
phenotypes in different cranial NCC derivatives [31,32].
To address if these receptors may be expressed in dis-
tinct populations of cranial NCCs, and thereby explain
the distinct migration phenotypes of neuropilin knock-
out embryos, we completed whole mount in situ hybrid-
isation on wild-type embryos between embryonic day (E)
8.5 to E9.5. By comparing the expression profiles of
Nrp1 and Nrp2 with that of the pan-NCC marker Sox10,
we found that neuropilins are expressed in different pop-
ulations of cranial NCCs. At E8.5 and E9.0, the time at
which NCCs have delaminated from the neural tube and
begun to migrate into the branchial arch tissue, the ex-
pression of Nrp1 was restricted to the stream of NCCs
emigrating out of r4, while Nrp2 was expressed recipro-
cally within NCCs emigrating out of r2 (Figure 1A-F).
At E9.5, this restricted expression pattern was maintained;
however, low levels of Nrp2 could also be detected in or
around the r4 stream of NCCs (Figure 1G-I). In addition
to this presumptive staining within NCCs, Nrp1 ex-
pression was identified in the heart, gut, and arteries
(Figure 1B, E, H), while Nrp2 expression was evident
in the dorsal regions of the heart (Figure 1C, F, I).
To investigate whether neuropilins are expressed in
NCCs and not other branchial arch tissue such as the
surface epithelia or cranial mesoderm, we sectioned E8.5
embryos transversely through the r2 and r4 regions, and
counterstained with antibodies specific to the neurotro-
phin receptor p75. Sox10 and p75 were co-expressed in
all migrating cranial NCCs at this stage of development
(Figure 1J-M). Consistent with the results of whole
mount staining, Nrp1 expression was identified specifically
in NCCs emigrating out of r4 and also within non-NCC tis-
sues such as the cranial mesoderm and the developing
heart (Figure 1N, P). Conversely, Nrp2 expression was re-
stricted to NCCs emigrating out of r2 and additional tissues
such as the cranial mesoderm, neural tube, and bulbus cor-
dis region of the developing heart (Figure 1R, T).
To compare expression of Nrp1 and Nrp2 in NCCs, we
immunostained embryos generated by crossing Wnt1Cre
[35] mice with Z/EG [36] reporter mice to specifically label
all NCCs and their derivatives with green fluorescent pro-
tein (GFP). Whole mount immunofluorescence stainingclearly demonstrated that Nrp1 and Nrp2 are expressed
in a reciprocal pattern, replicating the mRNA expres-
sion seen in our previous in situ hybridisation analysis
(Figure 2A-D). Immunostaining also identified expres-
sion of Nrp1 and Nrp2 in blood vessels around the r2
and r4 migrating NCCs (Figure 2A-D). Longitudinal
sections through the head confirmed this restricted expres-
sion along the anteroposterior axis, as well as expression
within the developing vasculature (Figure 2E-H). The
membrane localisation of neuropilins is consistent with
their role as cell surface receptors for guidance molecules
of the SEMA3 and VEGF families [30]. Taken together, our
in situ hybridisation, immunohistochemical, and lineage-
tracing analyses confirm that neuropilins are expressed in
different populations of cranial NCCs that are defined by
their position along the anteroposterior axis. These re-
stricted expression profiles therefore explain the disparate
phenotypes of neuropilin knockout mice in which Nrp1
has ectopically placed neurons of the facio-acoustic cranial
ganglia (VII-VIII) and Nrp2 has ectopically placed neurons
of the trigeminal ganglia (V) [31,32]. Future work address-
ing how the expression of neuropilins is controlled should
provide essential clues to the mechanisms dividing cranial
NCCs into distinct populations.
Nrp1 and Nrp2 are expressed in different populations of
trunk NCCs
Nrp1 and Nrp2 knockout embryos also displayed disparate
phenotypes in different trunk NCC derivatives [33,34]. To
explore if neuropilins are also expressed in different popu-
lations of ventrally migrating trunk NCCs, we compared
their expression with that of the pan-NCC markers Sox10
and p75 over the forelimb region of E9.5 embryos. In situ
hybridisation confirmed that Nrp1 was expressed within
NCCs migrating in the anterior half of the somite and in
non-NCC derivatives such as the dorsal aorta and interso-
mitic blood vessels (Figure 3B). Nrp2 was robustly
expressed in the anterior half of the somite in a pattern
that partially overlapped with Sox10 (Figure 3C). To de-
termine if neuropilins are expressed within NCCs or
the supporting somitic tissue, we next counterstained
longitudinal in situ hybridisation sections with anti-p75
antibodies (Figure 3D-I). In addition to labelling Sox10-
expressing NCCs, p75 also recognised neuroepithelial cells
within the neural tube (Figure 3D, G). Co-staining of Nrp1
and p75 within the anterior half of the somite indicated
that Nrp1 was expressed in trunk NCCs migrating along
the ventral path (Figure 3E, H). In addition, Nrp1 was also
expressed in the posterior somite and within intersomitic
blood vessels. Nrp2 was broadly expressed throughout the
entire anterior half of the somite, with some cells co-
staining with p75 (Figure 3F, I).
To investigate whether neuropilins are co-expressed or
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Figure 1 Nrp1 and Nrp2 are expressed in different populations of cranial NCCs. (A-I) Whole mount in situ hybridisation of E8.5 to E9.5
wild-type embryos to determine the expression profiles of Nrp1 and Nrp2. (A, D, G) Sox10 labelled all migrating cranial NCCs and defined the r2
(open arrowhead), r4 (closed arrowhead) and r6 populations at E8.5, E9.0, and E9.5 as well as the otic vesicle (ov) at E9.5. (B, E, H) Nrp1 was
specifically expressed in the r4 stream of NCCs and not in the r2 stream. (C, F, I) Nrp2 expression was restricted to the r2 stream of NCCs and was
lacking in the r4 stream at E8.5 and E9.0. At E9.5, low levels of Nrp2 could be detected in the tissue ventral to r4. (J-U) Transverse in situ hybridisation
sections of E8.5 embryos through the regions of the r2 and r4 streams counterstained for the neurotrophin receptor p75. (J-M) Sox10 and p75
identified all migrating NCCs. p75 staining was also evident in the epithelia in close association with migrating NCCs in the region ventral to r4. (N-Q)
Transverse sections confirmed that Nrp1 is specifically expressed in the r4 NCC stream as well as the developing heart and cranial mesoderm (cm).
(R-U) Transverse sections confirmed that Nrp2 was restricted to the r2 stream of NCCs as well as the neural tube, cranial mesoderm, and developing
heart. IS, in situ hybridisation; e, eye; h, heart, r2, rhombomere 2; r4, rhombomere 4; ov, otic vesicle; e, eye. Scale bar = 100 μm.
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escence analysis on E9.5 Wnt1Cre; Z/EG embryos.
Whole mount staining for GFP, Nrp1 and Nrp2 identi-
fied mixed populations of NCCs expressing the neuropi-
lin receptors (Figure 4A-E). Consistent with our in situhybridisation analysis results, Nrp1 was identified in
NCCs in the anterior half of the somite, the intersomitic
blood vessels, and the dorsal aorta (Figure 4D). Nrp2
was also expressed in NCCs in the anterior half of the so-
mite in addition to the intersomitic blood vessels. Notably,
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Figure 2 Nrp1 and Nrp2 expression defines distinct cranial NCC populations along the anteroposterior axis. (A-D) Whole mount
immunofluorescence analysis of Nrp1 and Nrp2 on E9.0 Wnt1Cre; Z/EG embryos in which all NCCs were labelled by GFP expression (B). In
addition to staining of NCCs, both Nrp1 and Nrp2 were present in blood vessels within and around the r2 and r4 streams. (C-D) Antibody
staining showed that Nrp1 expression was restricted to the r4 stream of NCCs (closed arrowhead) and Nrp2 was restricted to the r2 stream of
NCCs (open arrowhead). (E-H) Longitudinal sections through the head confirmed that Nrp1 expression was indeed within NCCs of the r4 stream
and not in the r2 stream (delta), while Nrp2 staining was within NCCs of the r2 stream and not in the r4 stream (closed arrowhead). Nrp1 and
Nrp2 antibodies also labelled the major blood vessels (bv). e, eye; ov, otic vesicle. Scale bar = 100 μm.
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sion domains, and NCCs expressing high levels of Nrp1
with low or absent Nrp2 could be identified in the dorsal
regions of the somite (Figure 4A-E arrow).
To define the expression of neuropilins within individ-
ual trunk NCCs, we next analysed transverse sections of
E9.5 embryos taken from the anterior half of the somite
at the level of the developing forelimb (somites 13–14,
Figure 4F). Consistent with the whole mount staining re-
sults, we identified Nrp1 within migrating NCCs, the
dorsal aorta, and the periaortic mesenchyme. Nrp2 was
also identified in NCCs and NCC precursors within the
neural tube, the floor plate, somitic mesenchyme, and
anterior cardinal veins. Notably, NCCs located around
the dorsal aorta that had sympathetic fate preferentially
expressed Nrp1 (Figure 4Fii, white arrow). Moreover,
NCCs with presumptive sympathetic fate migrating to-
wards the dorsal aorta also preferentially expressed high
levels of Nrp1 (Figure 4Fii and inset). By contrast, NCCs
migrating within the somite and/or arresting within the
anlagen of the DRG expressed various combinations of
the neuropilin receptors. Although the majority of the
NCCs within the area of the DRG co-expressed Nrp1
and Nrp2, we also identified NCCs within and around the
DRG that preferentially expressed either Nrp1 (Figure 4Fi,
arrow) or Nrp2 alone (Figure 4Fi and inset). NCCs ex-
pressing only Nrp1 were mostly located at the ventral side
of the DRG in close association with the neural tube, whileNCCs expressing only Nrp2 were located at the prospect-
ive dorsal root entry zone.
We tested the notion that NCCs express combinations
of the neuropilin receptors by purifying GFP-positive
trunk NCCs from E9.5 Wnt1Cre; Z/EG embryos, using
fluorescence-activated cell sorting (FACS). Consistent with
our in vivo expression analysis, counterstaining of Nrp1
and Nrp2 identified three populations of trunk NCCs
based on their neuropilin expression profiles: 1) Nrp1
high/Nrp2 high, 2) Nrp1 high/Nrp2 low, and 3) Nrp2
high/Nrp1 low (Figure 5). Given the different locations of
these cells within the embryo, our expression profiling
also suggests that each of these NCC types may give rise
to different derivatives. We therefore propose that the ma-
jority of Nrp1 high/Nrp2 high NCCs form neurons and
glia of the DRG, Nrp2 high/Nrp1 low NCCs form bound-
ary cap cells at the dorsal root entry zone, and Nrp1 high/
Nrp2 low NCCs form neurons and glia of the sympathetic
nervous system.
Upon reaching the dorsal aorta, NCCs commence dif-
ferentiation into bona fide sympathetic neurons via the
elevated expression of the basic helix-loop-helix tran-
scription factor MASH1. NCC derivatives that have initi-
ated this differentiation program also begin to express
Nrp2 [37]. Consistent with this developmental progression,
our expression analysis in sections from more develop-
mentally advanced regions of E9.5 embryos (somites 5–6
that are anterior to the forelimb) identified a small number
Neuropilin1 Neuropilin2Sox10
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Figure 3 Nrp1 and Nrp2 are expressed in trunk NCCs at the same axial level. (A-C) Lateral view of whole mount in situ hybridisation at E9.5
for Sox10, Nrp1, and Nrp2. (A) Sox10 whole mount in situ hybridisation specifically labelled NCCs migrating through the anterior half of the somite
(black arrow). (B) Nrp1 in situ hybridisation labelled NCCs (black arrow), intersomitic blood vessels (white arrowhead) and the dorsal aorta (asterisks).
(C) Nrp2 was expressed within the anterior half of the somite (black arrow). (D-I) Longitudinal sections of Nrp1 and Nrp2 in situ hybridisation over the
hind limb counterstained with antibodies to p75. (D, G) p75 expression labelled Sox10-positive NCCs in the anterior half of the somite (white and
black arrow, respectively). (E, H) Nrp1 had its highest expression in cells that also expressed p75 (black and white arrows), and was also expressed in
the somitic tissue and intersomitic blood vessels. (F, I) Nrp2 was expressed in the anterior half of the somite within NCCs and also in the somitic tissue
(black and white arrows). a, anterior; IS, in situ hybridisation; p, posterior. Scale bars = 100 μm.
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Nrp1 and Nrp2 (not shown).
Previous phenotypic analysis of neuropilin knockout
embryos found that Nrp1 is required for correct position-
ing of both sensory and sympathetic neurons, while Nrp2
is required for positioning of sensory neurons [28,33,34].
Our expression analysis therefore explains the disparate
phenotypes between the two types of knockout mice, and
further suggests that neuropilins may play essential roles
in coordinating NCC migration with fate specification.
Generation of an inducible lineage-tracing Nrp2 transgenic
mouse model
To identify the fate of neuropilin-expressing NCCs and
to determine if Nrp2-expressing trunk NCCs are biased
towards the sensory neuronal lineage, we generated a
tamoxifen-inducible Nrp2 lineage-tracing mouse model.
A Nrp2-CreERT2/Kikume transgenic construct was gen-
erated by replacing the ATG start codon of the Nrp2
gene with the entire CreERT2 IRES Kikume sequence
followed by a polyadenylation signal sequence, thus pla-
cing CreERT2 IRES Kikume under control of the en-
dogenous regulatory elements contained in the Nrp2
gene locus (Figure 6A). The engineered construct was
used to generate a transgenic founder mouse that was
identified by PCR using primers specific for CreERT2.The offspring from the founder line appeared grossly
normal, and the transgene was transmitted as predicted
by Mendelian ratios.
To permanently label and follow the fate of Nrp2 ex-
pressing cells throughout embryogenesis, Nrp2-CreERT2/
Kikume transgenic mice were crossed with R26R LacZ re-
porter mice to create Nrp2-CreERT2/Kikume; R26R LacZ
embryos. Upon addition of tamoxifen to these embryos,
CreERT2 translocated to the nucleus to promote stable
expression of β-galactosidase (lacZ) in cells and descen-
dants of cells endogenously expressing Nrp2 at the time of
injection. No lacZ labelling was detected without tamoxi-
fen injection (data not shown).
We next determined that intraperitoneal injection of
tamoxifen at 2–4 mg per 40 g body weight to pregnant
dams was sufficient to label Nrp2-expressing cells with-
out resulting in embryonic lethality. As expected, higher
doses of tamoxifen injected at E7.5 to E8.5 had detri-
mental effects on embryos.
Having optimised the dosage of tamoxifen, we first val-
idated that the transgene recapitulated the Nrp2 expres-
sion profile in NCCs. Tamoxifen was injected at E9.0
and E9.5, and embryos collected at E10.0. Analysis of X-
gal staining in whole mount embryos demonstrated that
the transgene is expressed in a highly overlapping pat-
tern to endogenous Nrp2 (n = 12; compare Figure 6B
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Figure 5 NCCs express combinations of Nrp1 and Nrp2. (A-D) FACS of GFP-positive trunk NCCs from E9.5 Wnt1Cre; Z/EG embryos plated on
fibronectin and stained with antibodies to Nrp1 and Nrp2. (B) GFP was identified in all FACS-sorted cells. (C-D) Nrp1 and Nrp2 were co-expressed
in most NCCs. (i-i′) Some NCCs expressed high levels of Nrp2 and low levels of Nrp1. (ii-ii′) Some NCCs expressed high levels of Nrp1 and low
levels of Nrp2. Scale bar = 100 μm.
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Figure 4 Nrp1 and Nrp2 are expressed in distinct populations of trunk NCCs. (A-E) Lateral view of whole mount immunofluorescence
staining of Nrp1, Nrp2 and trunk NCCs at E9.5. (C) GFP labelled all NCCs migrating in the anterior half of the somite. (D) Nrp1 was expressed in many
GFP-positive NCCs and intersomitic vessels. (E) Nrp2 was expressed in the anterior half of the somite and within NCCs. Notably, Nrp1 had high expression
in NCCs that had either low or negative Nrp2 expression (white arrow). (F) Transverse sections through the anterior half of the somite over the forelimb
region showed that neuropilins were expressed within different populations of NCCs. NCCs migrating through the somite in and around the anlage of
the dorsal root ganglia (Fi-i′′′) consisted of cells with high Nrp2 and no Nrp1 expression (inset) and conversely, with high levels of Nrp1 and no expression
of Nrp2 (white arrow). (Fii-ii′′′) NCCs migrating towards the dorsal aorta (inset) or condensing in the region of the sympathetic ganglia (white
arrow) preferentially expressed Nrp1. av, anterior cardinal vein; bv, blood vessel; da, dorsal aorta. Scale bars = 100 μm.
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Figure 6 Generation of Nrp2-CreERT2/Kikume lineage-tracing mice. (A) The Nrp2- CreERT2/Kikume transgenic construct consisted of a BAC
(RP24-250G22) encompassing 62 kb upstream of the Nrp2 start codon and 4 kb downsteam of the 3′ UTR. A cassette consisting of the sequences
for CreERT2, IRES ,and Kikume tagged in-frame to the FLAG tag was inserted in place of the start codon of Nrp2. (B-D) Whole mount X-gal staining
of E10.0 Nrp2-CreERT2/Kikume X R26R embryos injected with tamoxifen (TM) at E9.0 and E9.5 (arrows). (B,C) In the head, X-gal staining was present
in NCCs condensing into the anlagen of the Vth cranial ganglia (dashed circle) and not the VII-VIIIth cranial ganglia. (B, D) In the trunk, X-gal staining was
present within the anterior somite. (E-H) Whole mount embryos were sectioned and counterstained with p75. (E-F) Transverse sections through r2
showed that LacZ expression occurred within NCCs (arrow). (G-H) Longitudinal sections through the trunk show that LacZ expression occurred within
migrating trunk NCCs (arrow). e, eye; h, heart; nt, neural tube; ov, otic vesicle; *, collection of embryos. Scale bars = A, 10 kb; B, 500 μm; D, 100 μm.
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expression pattern replicated the expression of Nrp2
within a distinct striped pattern in the trunk and
within NCCs migrating out of r2 (Figure 6B-D). To
confirm that the expression was occurring within
NCCs, we sectioned E10.0 embryos and counterstained
with the NCC marker p75 (Figure 6E-H). Transverse
sections through r2 and longitudinal sections through
the trunk confirmed transgene expression withinmigrating NCCs, somitic tissue, and other cell types
within the epidermis (detailed analysis of transgene ex-
pression in other tissues will be presented elsewhere).
These findings demonstrate that the regulatory ele-
ments controlling expression of Nrp2 within NCCs are
present within the bacterial artificial chromosome (BAC)
used to make this transgenic animal. This mouse model
provides an ideal resource for lineage-tracing studies and
for the temporal removal of floxed genes in specific NCC
Lumb et al. Neural Development 2014, 9:24 Page 9 of 14
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expressed.
Nrp2-expressing NCCs give rise to neurons and glia in the
trigeminal ganglia
Using this inducible lineage-tracing mouse model, we first
determined the derivatives of Nrp2-expressing NCCs
in the head. Tamoxifen was administered to pregnant
dams when embryos were at E9.5 and E10.0, and later
collected at E11.5. Consistent with Nrp2 being restricted
to specific cranial NCC subpopulations, analysis of whole
mount embryos revealed distinct X-gal staining in the tri-
geminal (V) ganglia that are derived from NCCs migrating
out of r2 (n = 8, Figure 7A). By contrast, minimal staining
was detected in r4 NCC derived structures such as the
facio-acoustic ganglia (VII-VIII). X-gal staining also identi-
fied additional Nrp2-expressing cells in the forebrain
















Figure 7 Nrp2-expressing NCCs give rise to neurons and glia of the t
CreERT2/Kikume X R26R embryos injected with tamoxifen (TM) at E9.5 and E
were derived from the r2 stream of NCCs. Notably, staining was absent from
(VII-VIII). (B-C) Longitudinal sections through the head of Nrp2-CreERT2/Kikume
transgene expression was restricted to the trigeminal ganglia (V) and lacking
(B) counterstained for X-gal, Tuj1, and Sox9 confirmed transgene expression w
facio-acoustic ganglia (VII-VIII). (D) Bright-field (BF) images of X-gal staining ov
promote colocalisation analysis. (Gi-Gi′′′ X-gal-positive descendants of Nrp2-e
descendants of Nrp2-expressing NCCs co-expressed Sox9 (arrow). Scale bars =confirmed the restriction of Nrp2-expressing NCCs to the
trigeminal ganglia (V) (Figure 7B-C).
To define the fate of Nrp2-expressing NCCs, we next
counterstained longitudinal X-gal-stained sections with
antibodies specific for neurons (anti-Tuj1 antibodies) and
glia (anti-Sox9 antibodies) (Figure 7D-G). Under high
magnification, Nrp2-expressing NCCs were found to give
rise to both Tuj1-positive neurons and Sox9-positive glia
within the trigeminal ganglia (V) (Figure 7Gi, Gii, respect-
ively). Taken together with our expression profiling re-
sults, we conclude that Nrp2 expression is restricted to
NCCs emigrating out of hindbrain r2. As we were unable
to detect X-gal staining in other derivatives of the r2
stream such as bone and cartilage of the mandible, our re-
sults suggest that Nrp2-expressing NCCs preferentially
give rise to neuroglial lineages. In addition, both whole
mount staining and staining of transverse sections (not







rigeminal ganglia. (A) Whole mount X-gal staining of E11.5 Nrp2-
10.0 (arrows). Staining was restricted to the trigeminal ganglia (V) that
derivatives of the r4 stream of NCCs such as the facio-acoustic ganglia
X R26R embryos counterstained for X-gal and eosin confirmed that
in the facio-acoustic ganglia (VII-VIII). (D-G) Serial sections to that in
ithin neurons and glia of the trigeminal ganglia (V) and not within the
erlaid with Tuj1 and Sox9. (G) BF images were colour-inverted to cyan to
xpressing NCCs co-expressed Tuj1 (arrow). (Gii-Gii′′′) X-gal-positive
A, 500 μm; D, G, 100 μm.
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http://www.neuraldevelopment.com/content/9/1/24Schwann cells along the axonal tracts of the trigeminal
ganglia (V).
Nrp2-expressing trunk NCCs are biased towards sensory
ganglia
Our expression analysis raised the hypothesis that ven-
trally migrating trunk NCCs expressing Nrp2 are biased
towards neurons and glia of the sensory ganglia. To test
this notion, we completed fate-mapping studies with the
Nrp2-inducible lineage-tracing mouse model. Tamoxifen
was administered to pregnant dams when embryos were
E9.5 and E10.0, and these were later collected at E11.5, a
stage at which the sensory and sympathetic ganglia have
started to condense. Consistent with the staining of
Nrp2 in NCCs and paraxial mesoderm at E9.5, X-gal
staining identified derivatives of Nrp2-expressing cells
within the DRG and skeletal muscle (Figure 8A). Eosin
staining of longitudinal sections anterior to the hind
limb clearly demonstrated X-gal staining within the
DRG (Figure 8B-C). Transverse sections through the
same axial level were also counterstained with the pan













Figure 8 Nrp2-expressing NCCs give rise to neurons and glia of the d
CreERT2/Kikume X R26R embryos injected with tamoxifen (TM) at E9.5 and E
skin, and DRG. (B-C) Longitudinal sections anterior to the hind limbs count
and glia of the DRG, skeletal muscle and skin. (D-I) Transverse sections ante
X-gal staining within sensory neurons of the DRG (E-F, dashed circle) but n
neural tube. Scale bars = A, 500 μm; D & G, 100 μm.neuronal marker tyrosine hydroxylase (TH) (Figure 8D).
In all cases examined (n = 3), X-gal staining was robustly
observed in the DRG (Figure 8D-F). By contrast, we
were unable to observe X-gal staining in sympathetic
ganglia (Figure 8G-I). This finding demonstrates that
Nrp2-expressing NCCs are strongly biased towards neu-
rons and glia of the DRG.
Our fate-mapping results of Nrp2-expressing NCCs
are strikingly similar to that presented for lineage tracing
of Ngn2-expressing NCCs in mice [17]. In the latter,
Ngn2-positive cells were also biased towards sensory
ganglia. As Ngn2 is a basic helix-loop-helix transcription
factor that plays an essential role in sensory neuronal
differentiation [38], it will be of interest to determine if
Nrp2 is also involved in the same molecular pathway
within NCCs.
Conclusions
The work presented here identified molecularly distinct
populations of cranial and trunk NCCs based on their
expression profiles of the cell surface receptors Nrp1













orsal root ganglia. (A) Whole mount X-gal staining of E11.5 Nrp2-
10.0 (arrows). Staining was identified in presumptive skeletal muscle,
erstained with eosin confirmed X-gal staining within sensory neurons
rior to the hind limbs counterstained with Tuj1 and TH demonstrated
ot within sympathetic neurons (G-I, dashed circle). da, dorsal aorta; nt,
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identifies essential roles for neuropilins in sorting spe-
cific populations of NCCs to their final destinations
within the embryo (Figure 9A). In the head, Nrp1 is
expressed in NCCs emigrating from r4, and is required
for the migration and condensation of neurons and glia
of the facio-acoustic ganglion (VII-VIII) [31]. By con-
trast, Nrp2 is expressed in NCCs emigrating from r2,
and is required for the migration and condensation of
neurons and glia of the trigeminal ganglion (V) [32].
In addition to their differential expression in restricted
populations of NCCs along the anteroposterior axis,
neuropilins also label divergent populations of NCCs
along the dorsoventral axis (Figure 9A). Trunk NCCs
migrating along the ventral path through the anterior
somite consist of a mixed population of sympathetic and
sensory progenitors. Our finding that Nrp1 and Nrp2
expression correlates with sympathetic and sensory pro-
genitors, and that Nrp2-expressing NCCs are biased to-

















Figure 9 Neuropilins define molecularly distinct populations of ventr
expression profiles in migrating trunk NCCs. NCCs migrating to the dorsal a
within the somite alongside the neural tube (nt) give rise to sensory neuro
delaminate from the neural tube at E8.5, and by E9.0, have started to migra
dorsal aorta, while others have stalled in the anlagen of the DRG. At E10.5,
fate have started differentiating in the DRG. Expression profiling identified dist
(purple). Nrp1-expressing cells preferentially migrate towards the dorsal ao
was also expressed in presumptive NCC precursors within the dorsal neur
NCCs. NCCs delaminate from the neural tube to migrate along two separate
space to seed the sympathetic ganglia, and then switch to travel ventrally thr
sympathetic ganglia, and melanocytes. NCCs migrating dorsolaterally also giv
suggest that Nrp2 (Nrp2 alone (blue) and Nrp1/Nrp2 (purple)) is a marker of N
phenotypic studies suggest that Nrp1 (red) is a marker of ventrally migratingtherefore suggests that neuropilins, possibly in combin-
ation with other guidance molecules such as CXCR4
[25], provide part of the molecular machinery to guide
ventrally migrating NCC precursors to correct target re-
gions of the embryo (Figure 9B). Indeed, phenotypic
analysis of neuropilin knockout mice is in strong agree-
ment with this notion [33,34].
Our study identified three distinct NCC sub-types
within and around the DRG that can be segregated based
on their neuropilin expression profiles. While Nrp2-
expressing NCCs (Nrp2-high/Nrp1-high and Nrp2-high/
Nrp1-low) were traced to the DRG it will be important to
complete the inverse experiment with lineage tracing of
Nrp1-expressing NCCs to determine if this population is
also fate-restricted.
Our expression analysis also identified Nrp2 within
presumptive NCC precursors in the dorsal neural tube
(Figure 4F). Given that Nrp2 knockout embryos have de-
fects restricted to sensory NCC derivatives, and that










ally migrating trunk NCCs. (A) Schematic detailing the neuropilin
orta (da) give rise to the sympathetic ganglia, while NCCs that stall
ns of the DRG. Trunk NCCs at the level of the forelimb begin to
te within the somite. At E9.5, some NCCs have already reached the
NCCs with sympathetic fate have condensed, while NCCs with sensory
inct populations of NCCs with Nrp1 (red), Nrp2 (blue), and Nrp1/Nrp2
rta while Nrp2-expressing cells stall within the area of the DRG. Nrp2
al tube. (B) Schematic diagram detailing the fate restriction of trunk
paths. Ventrally migrating NCCs initially travel through the intersomitic
ough the anterior half of the somite to give rise to sensory ganglia,
e rise to melanocytes. Expression, fate-mapping, and phenotypic studies
CCs biased towards sensory ganglia. In addition, expression and
NCCs that give rise to sympathetic ganglia.
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port the notion that at least some pre-migratory NCCs
are fate-biased prior to delamination. However, as clonal
analysis or transplantation of Nrp2-expressing pre-
migratory/migrating NCCs into ectopic environments
has not yet been achieved, our studies are currently un-
able to decipher between the two models of when ven-
trally migrating NCCs are segregated into specified
lineages. For example, although the Nrp2-expressing
cells may be biased towards a sensory phenotype, they
may only commit to this lineage upon reaching their
final resting place within the sclerotome.
Taken together with previous reports, our studies
demonstrate that neuropilins provide part of the mo-
lecular machinery to sort heterogeneous populations of
ventrally migrating NCCs towards correct target regions.
Methods
Mice
All experimentation was approved by and conducted in
accordance with the guidelines of the Animal Ethics
Committee of the SA Pathology/Central Adelaide Local
Health Network, and followed the Australian code of
practice for the care and use of animals for scientific
purposes. To obtain embryos of defined gestational ages,
animals were mated in the evening, and the morning of
vaginal plug formation was counted as embryonic day
(E) 0.5. To lineage-trace NCCs and their derivatives
throughout development, we crossed Wnt1Cre [35] with
Z/EG [36] mice.
Generation of Nrp2-CreERT2/Kikume transgenic mice
The BAC clone RP24-250G22, containing 62 kb of DNA
upstream of the first exon to 4 kb past the final coding
exon of the Nrp2 locus, was obtained from the BAC re-
source at Children’s Hospital Oakland Research Institute
(Oakland, California, USA). A CreERT2 IRES FLAG-
Kikume cassette was inserted at the initiation codon of
the Nrp2 coding sequence, which is located within exon
1, by homologous recombination using a targeting vec-
tor designed for BAC recombineering [39,40]. A 5′ hom-
ology arm was amplified by PCR with a forward primer
5′-taactagtctcgagctctgggaacacagagctgag-3′ and reverse
primer 5′-taactagtagagagcgatccgattacg-3′ and inserted up-
stream of the CreERT2 IRES FLAG-Kikume sequence in
plasmid pBS-CreERT2 IRES FLAG-Kikume (Schwarz
laboratory). The 5′ homology arm and CreERT2 IRES
FLAG-Kikume fragment was then sub-cloned to the
recombineering vector PL451 using XhoI restriction
sites. A 3′ homology arm was amplified by PCR with a
forward primer 5′-taggatccgtaagcccttcaaagtttttc-3′ and
reverse primer 5′-tagcggccgcaaagaatccacacatgtgaaaag-3′,
and inserted downstream of CreERT2 IRES FLAG-Kikume
Neo/Kan in the PL451 vector using unique BamHI/NotIsites. This created the Nrp2- CreERT2/Kikume PL451 re-
combineering vector.
The RP24-250G22 BAC was transformed into the
recombinogenic Escherichia coli strain EL250 and main-
tained with chloramphenicol resistance. EL250 cells car-
rying RP24-250G22 BAC were electroporated with
Nrp2-CreERT2/Kikume PL451, and homologous recom-
bined positive clones were selected with kanamycin and
chloramphenicol. The Neo/Kan cassette was removed by
L-arabinose induction of flp recombinase, resulting in a
Nrp2-CreERT2/Kikume BAC. Homologous recombin-
ation was confirmed by PCR and sequencing of the BAC
using primers that flanked upstream of the Nrp2 5′
homology arm and downstream of the 3′ homology
arm. High-quality BAC DNA was prepared using the
Large Construct Kit (Qiagen, Chadstone, VIC, Australia)
and analysed by pulsed field gel electrophoresis, restric-
tion analysis, and BAC end sequencing. Prior to micro-
injection, the DNA elution buffer was replaced with
fresh microinjection buffer (10 mM Tris–HCl, pH 8.0
0.25 mM EDTA, pH 8.0) by microdialysis. The Nrp2-
CreERT2/Kikume BAC was microinjected into fertilized
embryos by standard pronuclear injection techniques at the
Transgenic Animal Services Queensland (TASQ, Brisbane,
GLD, Australia). Genomic DNA was isolated from tail
samples [41], and founder mice carrying the BAC trans-
gene were identified by PCR with primer pairs recognising
CreERT2: iCre forward 5′-gagagatggatctctgtgtc-3′ and
iCre reverse 5′-gacttcatcagaggtggcatc-3′, yielding a 580 bp
product. Founders and offspring were subsequently geno-
typed with the same primer pair. One founder line was
produced that transmitted the transgene in a normal men-
delian inheritance pattern, with all offspring appearing
grossly normal.
In situ hybridisation
Whole mount and section in situ hybridisation was per-
formed as described previously [42]. Riboprobes were
transcribed from plasmids containing the cDNA se-
quence for Sox10, Nrp1, and Nrp2 [33,34].
Immunolabelling
Embryos were fixed in 4% paraformaldehyde in PBS. All
sections were cut at a thickness of 14 μm on a CM1850
cryostat (Leica, North Ryde, NSW, Australia) and air-
dried for 60 min before staining. For immunolabelling,
cryosections or whole mount embryos were blocked in
PBS containing 0.2% BSA and 0.5% Triton X-100, and
stained with the indicated primary antibodies: rabbit
anti-Sox9 1:1000; rabbit tyrosine hydoxylase 1:300 (both
Millipore, Batswater, VIC, Australia); goat anti-Nrp1
1:500; rabbit anti-Nrp2 1:500 (both R&D, Minneapolis,
MN, USA); rabbit anti-p75-NTR 1:200 (Epitomics,
Burlingame, CA, USA); mouse anti β-tubulin isotype
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http://www.neuraldevelopment.com/content/9/1/24III (Sigma-Aldrich, Sydney, NSW, Australia) 1:750; and
chicken anti-GFP 1:1000 (Abcam, Melbourne, VIC,
Australia). Cyrosections were mounted in Prolong Gold
Antifade Reagent containing DAPI (Molecular Probes,
Mulgrave, VIC, Australia). Confocal images were acquired
under a confocal microscope (LSM 700; Zeiss, Jena,
Germany). All images were prepared with Photoshop soft-
ware (Adobe, San Jose, CA, USA).
β-Galactosidase staining
Embryos were fixed in PBS containing 4% paraformalde-
hyde. Whole embryos or cryosections were incubated in
staining solution: 19 mM sodium dihydrogen phosphate,
81 mM disodium hydrogen phosphate, 2 mM MgCl2,
5 mM EGTA, 0.01% sodium deoxycholate, 0.02% NP-40,
5 mM potassium ferricyanide, 5 mM potassium ferro-
cyanide, and 1 mg/ml X-gal substrate, at 37°C until blue
staining was sufficient. Sections were counterstained
with eosin.
Tamoxifen
Tamoxifen 1 g (Sigma-Aldrich, Sydney, NSW, Australia)
was suspended in 5 ml of ethanol, and then dissolved in
45 ml of sunflower oil to produce a final stock at 20 mg/ml
concentration. To dissolve the tamoxifen completely, the
stock was sonicated in an ice bath for 5 min (with 30 sec-
ond intervals). Pregnant dams were injected intraperitone-
ally with 2 mg tamoxifen per 40 g body weight at the
indicated time points.
FACS sorting of primary neural crest cells
Primary NCCs were isolated from E9.5 Wnt1Cre; Z/EG
embryos as previously described [43]. Trunk regions
posterior to somite 10 were dissociated using Tryple Ex-
press (Invitrogen, Mulgrave, VIC, Australia) for 10 mi-
nutes at room temperature. Dissociated cells were
washed twice with Dulbecco’s modified Eagle’s media
(DMEM) containing 10% fetal calf serum (FCS), and re-
suspended in DMEM with 1% FCS for cell sorting. Cell
sorting was performed on a Beckman Coulter Epics Altra
HyperSort using Expo MultiComp Software (v1.2B;
Beckman Coulter, Lane Cove, NSW, Australia) equipped
with an Innova 300C water-cooled 488 nm argon laser at
100 mW. Sorting was conducted at room temperature,
with the instrument pressurised to 12 psi and equipped
with a 100 μm nozzle. Linear forward scatter (FSC) peak
signal (pk), width (time of flight (TOF)) and internal signal
area (INT) signals were collected to allow for standard
scatter and doublet discrimination. Linear side scatter
(SSC) and INT signal were collected with a 488/10 band
pass filter in the photomultiplier tube (PMT1). Log GFP
signal was collected in PMT2 with a 525/25 band pass fil-
ter behind a 488 nm long pass dichroic mirror. A gate was
drawn on FSC versus SSC plot to exclude debris and deadcells, as discriminated by scatter properties alone. Follow-
ing this, an FSC pk versus FSC INT plot was examined to
allow distinction of single cells. Linearly related cells were
gated for further analysis on a GFP versus SSC plot. Cells
were collected into DMEM with 10% FCS. After
collection, primary NCCs were centrifuged, resuspended
in NCC growth media (DMEM F12, 5% chicken embryo
extract, 10 mM HEPES, 2% B27, 1% N2, 20 ng/ml
insulin-like growth factor (IGF, R&D, Minneapolis, MN,
USA), and 100 U/ml Penicillin/Streptomycin (Invitrogen,
Mulgrave, VIC, Australia). Cells were plated in this media
in Ibidi μ-slide eight-well dishes coated with 50 mg/ml
fibronectin (Roche, Basel, Switzerland) at a concentration
of 5 × 104 cells/well. After 4 hours, cells were fixed with
4% PFA for 10 minutes, and immunolabelled with anti-
Nrp1 and anti-Nrp2 antibodies. Images were acquired
on an Olympus IX81 microscope using Cell X-cellence
software (Olympus, Edwardstown, SA, Australia).
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